Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01353976 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis
A Phase 3 study, sponsored by AmDerma.
- Completed
- Registry status
- Phase 3
- Development phase
- 264
- Enrollment target
NCT01353976 is a Phase 3 study that has completed, run by AmDerma. The registered enrollment target is 264 participants.
The verdict
NCT01353976, a Phase 3 study, has completed, sponsored by AmDerma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 264 participants
- Enrollment target
Study Summary
This is a study of the safety and efficacy of topical Econazole Nitrate Foam 1% and the foam vehicle in subjects with interdigital tinea pedis (athlete's foot between the toes). This is a 6 week study which has a 4 week treatment period and a 2 week follow-up evaluation.
Interventions
- DRUG Econazole Nitrate Foam 1%
- OTHER Vehicle Foam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 264 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01353976
The ClinicalTrials.gov registry entry for NCT01353976 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 264 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AmDerma, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Econazole Nitrate Foam 1% is the first listed.
NCT01353976 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01353976 about?
NCT01353976 is a clinical study titled "Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis". This is a study of the safety and efficacy of topical Econazole Nitrate Foam 1% and the foam vehicle in subjects with interdigital tinea pedis (athlete's foot between the toes). This is a 6 week study which has a 4 week treatment period and a 2 week follow-up evaluation.
What is the current status of trial NCT01353976?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 264 participants. The study started on 2011-05. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01353976?
The interventions under investigation include: Econazole Nitrate Foam 1% (DRUG), Vehicle Foam (OTHER).
Who is sponsoring clinical trial NCT01353976?
This trial is sponsored by AmDerma, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.